EUVIMEDEUVIMED entdecken
Crossref

The expediency of palliative (cytoreductive) gastrectomy as part of combined treatment for stage IV gastric cancer with cytological peritoneal carcinomatosis (Cy+). A literature review

D. V. Menshchikov, I. V. Krochek, S. V. Sergiyko, R. D. Ibatullin, E. V. Ishmekeeva, E. R. Ibragimov, D. A. Tyurbit

Perm Medical Journal · 10.07.2026 · 43 (3) · 20-33

DOI: 10.17816/pmj43320-33 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Perm Medical Journal, online erschienen am 10.07.2026. Verfasst von D. V. Menshchikov und 6 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer is one of the most common and aggressive malignant neoplasms with pronounced geographic heterogeneity. Stage IV disease with cytologic peritoneal carcinomatosis represents a distinct patient population, for whom the primary treatment is palliative systemic antitumor drug therapy without the possibility of surgical intervention under standard conditions. Cytoreductive surgery can reduce tumor burden, subsequently decreasing the risk of disease progression. Currently, clinical guidelines in the Russian Federation, the United States of America, and the European Union present different approaches to the treatment of such patients. Some authors use cytoreductive gastrectomy combined with systemic antitumor therapy, as well as hyperthermic intraperitoneal chemotherapy (HIPEC) and intraperitoneal aerosol chemotherapy (PIPAC), while other studies report conflicting results regarding surgical intervention and favor systemic antitumor therapy alone. There are no reliable data on the effectiveness of cytoreductive intervention for gastric cancer with cytological peritoneal carcinomatosis, either as an independent treatment or as part of combined therapy, which necessitates further research, observation and analysis.

Zitieren

APA

Menshchikov, D. V., Krochek, I. V., Sergiyko, S. V., Ibatullin, R. D., Ishmekeeva, E. V., Ibragimov, E. R., & Tyurbit, D. A. (2026). The expediency of palliative (cytoreductive) gastrectomy as part of combined treatment for stage IV gastric cancer with cytological peritoneal carcinomatosis (Cy+). A literature review. Perm Medical Journal, 43(3), 20-33. https://doi.org/10.17816/pmj43320-33

Vancouver

Menshchikov DV, Krochek IV, Sergiyko SV, Ibatullin RD, Ishmekeeva EV, Ibragimov ER, et al. The expediency of palliative (cytoreductive) gastrectomy as part of combined treatment for stage IV gastric cancer with cytological peritoneal carcinomatosis (Cy+). A literature review. Perm Medical Journal. 2026;43(3):20-33. doi:10.17816/pmj43320-33

BibTeX
@article{Menshchikov2026,
  author = {Menshchikov, D. V. and Krochek, I. V. and Sergiyko, S. V. and Ibatullin, R. D. and Ishmekeeva, E. V. and Ibragimov, E. R. and Tyurbit, D. A.},
  title = {The expediency of palliative (cytoreductive) gastrectomy as part of combined treatment for stage IV gastric cancer with cytological peritoneal carcinomatosis (Cy+). A literature review},
  journal = {Perm Medical Journal},
  year = {2026},
  volume = {43},
  number = {3},
  pages = {20--33},
  doi = {10.17816/pmj43320-33}
}
Kostenlos starten →